Literature DB >> 10687877

Andropause.

A Vermeulen1.   

Abstract

Although, in distinction to middle aged women, in middle aged men there does not occur a sudden arrest of gonadal functions, fertility persisting until very old age, aging in men is, nevertheless, associated with an gradual decline of both endo- and exocrine testicular function. Whereas age has in fact only minimal effects on the quality of the ejaculate, endocrine function declines steadily with age and at age 75 years, mean plasma testosterone levels are only 65% of levels in young adults whereas over 25%, of these men have bioavailable testosterone levels below the lower normal limit in young adults. The interindividual variations in the plasma levels are, however, very important and a quarter of men over 75 years old, have still testosterone levels within the upper quartile of values in young men. Aging is accompanied by a series of signs and symptoms, many of which are rather similar to those observed in young hypogonadal males. The etiology of these signs and symptoms is often multifactorial, and very few correlations have been found between symptoms and plasma testosterone levels. Nevertheless, there is good evidence that the age associated decrease in testosterone levels is at least a co-determinant of these symptoms and testosterone supplementation has shown favorable effects on many of them. Side effects of this substitutive therapy are minimal when care is taken to keep plasma testosterone levels within the physiological range. Clinical prostatic carcinoma is an absolute contra-indication for testosterone supplementation. So far, there are no indications that testosterone would stimulate the evolution of as subclinical prostatic carcinoma to a clinical carcinoma but it should be recalled that so far, only a small number of elderly males received substitutive androgen treatment for longer periods in controlled studies. Hence, although side effects are generally minimal, one should, nevertheless, await the results of larger, long term, well-controlled studies before to recommend the routine testosterone substitution of elderly men.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10687877     DOI: 10.1016/s0378-5122(99)00075-4

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  27 in total

1.  Effects of apigenin on steroidogenesis and steroidogenic acute regulatory gene expression in mouse Leydig cells.

Authors:  Wei Li; Akhilesh K Pandey; Xiangling Yin; Jau-Jiin Chen; Douglas M Stocco; Paula Grammas; Xingjia Wang
Journal:  J Nutr Biochem       Date:  2011-03       Impact factor: 6.048

Review 2.  Andropause: to treat or not to treat?

Authors:  S Basaria; A Dobs
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 3.  [Diagnosis of the "aging male"--what is recommended?].

Authors:  V S Lenk
Journal:  Urologe A       Date:  2005-10       Impact factor: 0.639

4.  Correlation between serum total testosterone and the AMS and IIEF questionnaires in patients with erectile dysfunction with testosterone deficiency syndrome.

Authors:  Jae Kang; Byeong Kuk Ham; Mi Mi Oh; Je Jong Kim; Du Geon Moon
Journal:  Korean J Urol       Date:  2011-06-17

Review 5.  [Male sexuality in the elderly].

Authors:  L Rinnab; A J Schrader; M Schrader; F Zengerling
Journal:  Urologe A       Date:  2012-10       Impact factor: 0.639

6.  Genetic influences on hippocampal volume differ as a function of testosterone level in middle-aged men.

Authors:  Matthew S Panizzon; Richard L Hauger; Lindon J Eaves; Chi-Hua Chen; Anders M Dale; Lisa T Eyler; Bruce Fischl; Christine Fennema-Notestine; Carol E Franz; Michael D Grant; Kristen C Jacobson; Amy J Jak; Michael J Lyons; Sally P Mendoza; Michael C Neale; Elizabeth Prom-Wormley; Larry J Seidman; Ming T Tsuang; Hong Xian; William S Kremen
Journal:  Neuroimage       Date:  2011-10-01       Impact factor: 6.556

7.  Interaction of APOE genotype and testosterone on episodic memory in middle-aged men.

Authors:  Matthew S Panizzon; Richard Hauger; Hong Xian; Eero Vuoksimaa; Kelly M Spoon; Sally P Mendoza; Kristen C Jacobson; Terrie Vasilopoulos; Brinda K Rana; Ruth McKenzie; Jeanne M McCaffery; Michael J Lyons; William S Kremen; Carol E Franz
Journal:  Neurobiol Aging       Date:  2013-12-27       Impact factor: 4.673

8.  Nocturnal Hypoxemia is Associated With Low Testosterone Levels in Overweight Males and Older Men With Normal Weight.

Authors:  Alonço Viana; Ana Carolina Daflon; Arnaldo Couto; Denise Neves; Maria Helena de Araujo-Melo; Robson Capasso
Journal:  J Clin Sleep Med       Date:  2017-12-15       Impact factor: 4.062

9.  Androgens protect against apolipoprotein E4-induced cognitive deficits.

Authors:  Jacob Raber; Gerold Bongers; Anthony LeFevour; Manuel Buttini; Lennart Mucke
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

10.  Involvement of the thromboxane A2 receptor in the regulation of steroidogenic acute regulatory gene expression in murine Leydig cells.

Authors:  Akhilesh K Pandey; Xiangling Yin; Randolph B Schiffer; James C Hutson; Douglas M Stocco; Paula Grammas; XingJia Wang
Journal:  Endocrinology       Date:  2009-03-26       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.